Статья
КОНСЕНСУС РОССИЙСКИХ ЭКСПЕРТОВ ПО ПРОБЛЕМЕ МЕТАБОЛИЧЕСКОГО СИНДРОМА В РОССИЙСКОЙ ФЕДЕРАЦИИ: ОПРЕДЕЛЕНИЕ, ДИАГНОСТИЧЕСКИЕ КРИТЕРИИ, ПЕРВИЧНАЯ ПРОФИЛАКТИКА И ЛЕЧЕНИЕ
Данный документ представляет официальную позицию Секции ВНОК «Метаболический синдром» и опубликован во всех журналах ВНОК («Кардиоваскулярная терапия и профилактика», «Российский кардиологический журнал» и «Рациональная Фармакотерапия в Кардиологии»).
1. Рекомендации экспертов ВНОК по диагностике и лечению метаболического синдрома. Кардиоваскулярная терапия и профилактика 2007;(5 приложение):5-32.
2. Рекомендации экспертов ВНОК по диагностике и лечению метаболического синдрома (Второй пересмотр). Кардиоваскулярная терапия и профилактика 2009;(6 приложение 2):5-32
3. PurnelJ.Q., BrunzellJ.D. The centralrole of dietary fat, not carbohydrate, in the insulin resistans syndrome. Curr Opin Lipidol 1997;8(1):17-22.
4. Stevens J., Cai J., Pamuk E.R., et al. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998;338: 1-7.
5. Lapidus L., Bengtsson C., Larsson B. et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984; 289:1257-61.
6. Дедов И.И., Мельниченко Г.А. Ожирение. М.: Медицинское ин- формационное агентство, 2008.
7. Despres J.P., Moorjani S., Lupien P.J. et al. Regional distribution of body fat, plasma insulin, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990;10:497-511.
8. Sims E.A., Danforth E. Jr., Horton E.S. et al. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 1973;29:457-96.
9. Piatti P.M., Monti L.D., Pacchioni M. et al. Forearm insulin-and-non-insulin mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels. Metabolism 1991;40:926-33.
10. Randle P.J., Garland P.B., Hales C.N., Newsholme E.A. The glucose-fatty acid cycle: its role in insulin sensitivity and metabolic disturbance of diabetes mellitus. Lancet 1963;1:785-9.
11. EvansD.J., Murrey R., KisselbahA.H. Relationship between skeletal muscles insulin resistance, insulin mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography. J Clin Invest 1984;74(4):1515-25.
12. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity — indused insulin resistance in mice lacking TNF alpha function. Nature 1997;389:610-4.
13. Dietschy J.M., Turley S.D., Spady D.K. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 1993;34:1637-59.
14. Reaven G.M., Lithell H., Landsberg L.Hypertension and associated metabolic abnormalities — the role of insulin resistance and the sympatoadrenal system. N Engl J Med 1996;334:374-81.
15. Fraze E., Donner C.C., Swislocki A.L. et al. Ambient plasma free fatty acid concentration in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 1985;61:807-11.
16. Flier J.S. Leptin resistance and obesity. Presented at the 60th Scientific Sessions of the American Diabetes Association.June 13, 2000; San�Antonio, Texas.
17. Randle P.J., Priestman D.A., Mistry S.C., Halsall A. Glucose fatty acid interactions and the regulation of glucose disposal.JCell Biochem 1994;55 Suppl:1-11.
18. Ferrari P., Weidmann P. Insulin, insulin sensitivity and hypertension. J Hypertens 1990;8:491-500.
19. Defronzo R.A., Goldberg M., Agus Z.S. The effect of glucose and in�sulin on renal electrolyte transport. J Clin Invest 1976;58:83-90.
20. DeFronzo R.A., Cooke C.R., Andres R. et al. The effect of insulin in renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55:845-55.
21. Kamide K., Hori M.T., Zhu J.H. et al. Insulin-mediated growth in aortic smooth muscle and the vascular rennin-angiotensin system. Hypertension 1998;32:482-7.
22. Taddei S., Virdis A., Chiadoni L. et al. The pivotal role of endothelium in hypertension. Medicographia 1999;21:22-9.
23. Laakso M. Epidemiology of diabetic dislipidemia. Diabetes Rev 1995; 3:408-22.
24. Alberti K.G., Eckel R.H., Grundy S.M. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.